VIM and breast carcinoma: Vimentin is a suitable marker to identify the human breast cancer cell line 231/LM2-4 (S3 Fig) derived from the parental MDA-MB-231, which express basal-like markers and has been classified as a post-epithelial mesenchymal transition cell line, due to the expression of vimentin and the absence of E-cadherin expression [46].